title: Deletions in the DNA-binding domain of the TP53 gene in v-src-transformed chicken cells.
abstract: We have examined the chicken TP53 tumor suppressor gene in v-src-transformed chicken tumor cells by reverse transcriptase-polymerase chain reaction and deoxyribonucleic acid (DNA) sequencing. Initially, we have detected frequent deletions of variable length in both DNA-binding and oligomerization domains of the TP53 in late as well as early in vitro passages of the chicken tumor cell line PR9692. This tumor cell line shows an immortal phenotype and acquires a metastatic potential that is unique in our experimental model of v-src-induced tumors in congenic chickens. Deletions in TP53 were also detected in an early passage of parallel in vivo subculture of the original v-src-induced tumor. In this case, tumor cells underwent replicative senescence later in tissue culture. Our results suggest that extensive deletions are efficient mechanisms of TP53 inactivation, occurring as early events during the immortalization of v-src-transformed chicken cells. Tumor cells with altered TP53 might, however, still be susceptible to growth control mechanisms, leading to withdrawal from the mitotic cycle in the early stage of the tumor lifeline.
authors.affiliation: Institute of Molecular Genetics, Academy of Sciences of the Czech Republic, Flemingovo nám. 2, 166 37 Prague, Czech Republic.
authors.forename: Katerina
authors.initials: K
authors.lastname: Trtková
authors.forename: Jirí
authors.initials: J
authors.lastname: Plachý
mesh_terms: D000818:Animals; D001483:Base Sequence; D002461:Cell Line, Transformed; D045744:Cell Line, Tumor; D002471:Cell Transformation, Neoplastic; D002645:Chickens / Q000235:genetics*; D020868:Gene Silencing; D016158:Genes, p53; D016391:Genes, src; D008969:Molecular Sequence Data; D009362:Neoplasm Metastasis; D016415:Sequence Alignment
references.citation: Cell Death Differ. 2000 Aug;7(8):685-96
references.pmid: 10918442
references.citation: Genes Chromosomes Cancer. 1992 Jan;4(1):1-15
references.pmid: 1377002
references.citation: Folia Biol (Praha). 2000;46(6):219-25
references.pmid: 11140854
references.citation: Nat Genet. 1999 Feb;21(2):187-90
references.pmid: 9988270
references.citation: Science. 1994 Jul 15;265(5170):346-55
references.pmid: 8023157
references.citation: Nat Rev Cancer. 2003 Apr;3(4):286-95
references.pmid: 12671667
references.citation: Biochim Biophys Acta. 2002 Jun 21;1602(2):114-30
references.pmid: 12020799
references.citation: Nature. 1991 Jun 6;351(6326):453-6
references.pmid: 2046748
references.citation: Oncogene. 2000 Jun 29;19(28):3164-71
references.pmid: 10918571
references.citation: Folia Biol (Praha). 2002;48(4):126-38
references.pmid: 12194199
references.citation: Mol Cell. 1999 Dec;4(6):915-24
references.pmid: 10635317
references.citation: Exp Cell Res. 2000 Jan 10;254(1):1-13
references.pmid: 10623460
references.citation: Cell. 2000 Jan 7;100(1):57-70
references.pmid: 10647931
references.citation: Immunogenetics. 1992;35(5):309-15
references.pmid: 1348493
references.citation: Oncogene. 2001 Aug 23;20(37):5118-23
references.pmid: 11526500
references.citation: Adv Cancer Res. 2001;82:55-84
references.pmid: 11447765
references.citation: Cancer Cell. 2002 Apr;1(3):289-98
references.pmid: 12086865
references.citation: Folia Biol (Praha). 2000;46(1):17-23
references.pmid: 10730878
references.citation: Nucleic Acids Res. 1988 Dec 9;16(23):11383
references.pmid: 3060861
references.citation: Nat Genet. 1992 Apr;1(1):45-9
references.pmid: 1301998
references.citation: J Lab Clin Med. 1994 Jun;123(6):817-23
references.pmid: 8201258
references.citation: Nature. 1999 Jul 29;400(6743):464-8
references.pmid: 10440377
references.citation: EMBO J. 1995 Apr 3;14(7):1372-81
references.pmid: 7729415
references.citation: Vaccine. 2001 Aug 14;19(31):4526-35
references.pmid: 11483280
references.citation: Genes Dev. 1999 Oct 15;13(20):2670-7
references.pmid: 10541553
references.citation: Proc Natl Acad Sci U S A. 2002 Dec 10;99(25):16226-31
references.pmid: 12446840
references.citation: Oncogene. 1999 Dec 13;18(53):7621-36
references.pmid: 10618702
references.citation: Cancer Cell. 2002 Nov;2(5):401-13
references.pmid: 12450795
references.citation: Curr Opin Genet Dev. 2003 Feb;13(1):77-83
references.pmid: 12573439
references.citation: J Exp Med. 1998 Nov 16;188(10 ):1795-802
references.pmid: 9815257
references.citation: Genes Dev. 1992 May;6(5):876-87
references.pmid: 1577279
references.citation: Oncogene. 2001 May 10;20(21):2671-82
references.pmid: 11420679
references.citation: Nature. 1997 Feb 6;385(6616):544-8
references.pmid: 9020362
references.citation: Science. 1998 Jan 16;279(5349):349-52
references.pmid: 9454332
references.citation: Immunogenetics. 1994;40(4):257-65
references.pmid: 8082891
references.citation: Curr Opin Cell Biol. 1998 Apr;10(2):262-7
references.pmid: 9561851
references.citation: Cancer Res. 1992 Sep 1;52(17):4773-8
references.pmid: 1380891
references.citation: Int J Cancer. 1993 Apr 1;53(6):983-7
references.pmid: 8386142
references.citation: Nature. 2001 May 17;411(6835):342-8
references.pmid: 11357141
references.citation: Biotechniques. 2000 Aug;29(2):234-6
references.pmid: 10948421
references.citation: Cell Growth Differ. 1995 Oct;6(10):1225-34
references.pmid: 8845299
references.citation: J Clin Oncol. 2001 Mar 1;19(5):1405-13
references.pmid: 11230485
references.citation: Exp Cell Res. 2002 Jan 15;272(2):199-208
references.pmid: 11777345
references.citation: Oncogene. 2000 Nov 20;19(49):5636-42
references.pmid: 11114744